Description 188Re-Rhenium Colloidal Sulfide is a specialized radiopharmaceutical treatment utilized in isotopic radiation synovectomy for addressing conditions in large-sized joints. This therapy delivers localized radiation directly to the affected joint to alleviate symptoms associated with arthritis and other joint disorders. Clinical Applications 188Re-Rhenium Colloidal Sulfide serves as the 188Re analogue… Continue Reading…
Description 188Re-Rhenium Etidronate, also known by its various designations such as 186Re-HEDP, hydroxyethylidene diphosphonate, 186Re-Etidronate, 188Re-Hydroxyethanediphosphonate, and 188Re-REK-1, is a radiopharmaceutical agent with significant applications in medical treatments. It is commercially available in India through BRIT/BARC for radiosynovectomy procedures. This compound is also being actively developed as a therapeutic agent… Continue Reading…
Description186Re-Rhenium Colloidal Sulfide is a widely recognized therapeutic agent employed in isotopic radiation synovectomy for treating medium-sized joints. This generic formulation, designated as 186Re-Rhenium Colloidal Sulfide, is particularly effective in delivering localized radiotherapy to joints affected by various arthritic conditions. Clinical ApplicationsThis formulation is primarily indicated for patients with rheumatoid… Continue Reading…
What is 169Er-Erbium Citrate? 169Er-Erbium Citrate is a specialized radiopharmaceutical therapy designed for isotopic radiation synovectomy, particularly targeting small joints such as those in the hands and feet. This treatment leverages the therapeutic benefits of radioactive isotopes to alleviate symptoms of joint-related conditions. Clinical Applications of 169Er-Erbium Citrate This therapy… Continue Reading…
90Y-Yttrium Citrate is a radiopharmaceutical compound used in nuclear medicine for therapeutic purposes. It consists of the radioisotope Yttrium-90 (90Y) bound to citrate, a chelating agent that helps in the delivery of the radioactive isotope to the target tissues. In the context of therapeutic radiosynovectomy for large joints such as… Continue Reading…
32P-Chromic Phosphate is a radiopharmaceutical compound that has been used in the treatment of various medical conditions, particularly in the field of nuclear medicine. This radiopharmaceutical consists of the radioisotope phosphorus-32 (32P) bound to chromic phosphate, a compound that facilitates the delivery of the radioactive phosphorus to target tissues within… Continue Reading…
Properties and Characteristics Erbium-169 (169Er) is a radioactive isotope that emits both gamma and beta radiation. It has a half-life of approximately 9.4 days, during which it releases gamma rays with an energy of 8 keV (0.16% emission probability) and beta particles at energies of 351 keV (55% intensity) and… Continue Reading…
Properties and Characteristics Erbium-165 (¹⁶⁵Er) is a beta-emitting radionuclide with a relatively short half-life of 10.4 hours, making it suitable for applications requiring rapid decay to minimize radiation exposure. It primarily emits beta particles with energies of 580 keV (53%) and 440 keV (47%), with no significant gamma emissions, which… Continue Reading…